Try our beta test site

Neoadjuvant Herceptin in Patients With Breast Cancer

This study has been terminated.
(Closed to accrual 4/19/2006 / Study doesn't qualify for reporting.)
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Mothaffar Rimawi, Baylor Breast Care Center
ClinicalTrials.gov Identifier:
NCT00133796
First received: August 22, 2005
Last updated: February 3, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2007
  Primary Completion Date: September 2005 (Final data collection date for primary outcome measure)